LY3076226 / Eli Lilly, ImmunoGen, AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LY3076226 / Eli Lilly
NCT02529553: A Study of LY3076226 in Participants With Advanced or Metastatic Cancer

Completed
1
25
Canada, US
LY3076226
Eli Lilly and Company
Advanced Cancer, Metastatic Cancer
03/18
03/18

Download Options